ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Bacterial infection"

  • 2018 American Transplant Congress

    Fosfomycin vs Other Antibiotics for UTI after Kidney Transplant

    O. Mgbako,1 J-.E. Ha,1 N. Topilow,2 E. Min,1 D. Taupin,1 V. Tatapudi,1 B. Gelb,1 S. Hochman.1

    1NYU Langone Health, New York; 2Mt Sinai West, New York.

    Urinary tract infection (UTI) is a frequent infectious complication in kidney transplant recipients (KTRs). Antibiotic resistance is common among urine bacterial isolates in this population.…
  • 2018 American Transplant Congress

    Assessment of Methenamine Hippurate for the Prevention of Recurrent Urinary Tract Infections in Adult Renal Transplant Recipients: A Single Center, Retrospective Study

    I. Hollyer,1 F. Varias,3 B. Ho,1 M. Ison.1

    1Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL; 2Grinnell College, Grinnell, IA.

    Background: Urinary tract infections (UTI) are common in renal transplant recipients (RTR). Methenamine hippurate is a non-antibiotic drug that inhibits bacterial growth in the bladder…
  • 2018 American Transplant Congress

    Association of Tacrolimus Adherence and Discontinuation with Sepsis Risk among Kidney Transplant Recipients

    J. Donnelly,1 P. MacLennan,1 R. Mannon,1 R. Saran,2 J. Baddley,1 H. Wang,3 G. McGwin, Jr.,1 P. Muntner.1

    1University of Alabama at Birmingham, Birmingham, AL; 2University of Michigan, Ann Arbor, MI; 3University of Texas Health Science Center, Houston, TX.

    OBJECTIVE: The association between post-transplant tacrolimus exposure and sepsis risk is currently unknown. We examined the associations of tacrolimus adherence and discontinuation with sepsis risk…
  • 2018 American Transplant Congress

    Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures

    L. Chen,1 D. Kamiyama,2 L. Francalacci,1 E. Zhu,2 M. Donnelley,2 N. Clayton,2 K. Alman,1 A. De Mattos,1 J. Brown.3

    1Transplant Nephrology, UC Davis Medical Center, Sacramento, CA; 2Pharmacy, UC Davis Medical Center, Sacramento, CA; 3Infectious Diseases, UC Davis Medical Center, Sacramento, CA.

    OBJECTIVES: To evaluate outcomes in renal transplant recipients who received organs from donors with positive blood or urine cultures.METHODS: We performed a retrospective, single-center study…
  • 2018 American Transplant Congress

    Risk of Bacteremia According to Transplant Induction Immunosuppression Regimen

    E. Misch, S. Kelley, G. Leverson, B. Astor, D. Kaufman.

    University of Wisconsin School of Medicine and Public Health, Madison.

    Background: Transplant immune suppression is designed to suppress the adaptive immune response and ensure graft survival, but may have unintended effects on innate immunity. Few…
  • 2018 American Transplant Congress

    Association of Immunosuppressive Therapy Regimen with Sepsis Outcomes among Kidney Transplant Recipients

    J. Donnelly,1 P. MacLennan,1 R. Mannon,1 R. Saran,2 J. Baddley,1 H. Wang,3 G. McGwin, Jr.,1 P. Muntner.1

    1University of Alabama at Birmingham, Birmingham, AL; 2University of Michigan, Ann Arbor, MI; 3University of Texas Health Science Center, Houston, TX.

    OBJECTIVE: Immunosuppressive therapy (IST) could impact sepsis outcomes by altering the host immune response. We examined the associations of IST regimens with sepsis outcomes among…
  • 2018 American Transplant Congress

    The Impact of Spontaneous Bacterial Peritonitis on Patient Outcomes after Liver Transplantation Using the Scientific Registry of Transplant Recipient (SRTR) Database

    D. Moonka,1 G. Divine,2 S. Nagai.3

    1Division of Gastroenterology and Hepatology, Henry Ford Health System, Detroit, MI; 2Public Health Sciences, Henry Ford Health System, Detroit, MI; 3Transplant Institute, Henry Ford Health System, Detroit, MI.

    Spontaneous bacterial peritonitis (SBP) is associated with abdominal inflammation and increased morbidity in patients with end-stage liver disease. However, SBP has generally not been associated…
  • 2018 American Transplant Congress

    Primary Oral Vancomycin Prophylaxis Reduces the Incidence of Clostridium difficile Infection among Lung Transplant Recipients

    V. Bajrovic, K. Brizendine.

    Cleveland Clinic Foundation, Cleveland, OH.

    Purpose: To determine the efficacy of primary oral vancomycin prophylaxis in reducing the incidence of Clostridium difficile infection (CDI) in the early post-op period among…
  • 2018 American Transplant Congress

    Mycoplasma hominis Infection in Lung Transplant Recipients: A Retrospective Case Series

    J. Wright,1,2 N. Law,4 M. Murray, S. Poutanen,1,2 S. Husain,1 S. Keshavjee,1 L. Singer,1 A. Humar,1 D. Kumar.1

    1UHN, Toronto, ON, Canada; 2University of Toronto, Toronto, ON, Canada; 3UC-San Diego, San Diego.

    Background: Mycoplasma hominis is increasingly recognized as a respiratory pathogen causing invasive disease in solid organ transplant (SOT) recipients. We reviewed the clinical characteristics, management…
  • 2018 American Transplant Congress

    Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review

    Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.

    Transplant Infectious Diseases, UHN, Toronto, ON, Canada.

    Introduction:Screening and therapy of latent tuberculosis infection (LTBI) is recommended in transplant candidates. However, data on therapy of LTBI with fluoroquinolones are limited. We aimed…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences